Dr. Michael J. Thirman M.D.
Hematologist-Oncologist | Hematology & Oncology
5841 S Maryland Ave Section Of Hematolog Chicago IL, 60637About
Dr. Michael Thirman specializes in the medical management of adults with leukemia, lymphoma, myelodysplastic syndromes, and myeloproliferative disorders. His laboratory focuses on the role of MLL and ...
Education and Training
Univ of Mi Med Sch, Ann Arbor Mi 1986
University of Michigan Medical School 1986
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
- EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.
- The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
- The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
- ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
- ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.
- The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.
- Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.
- Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).
- Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
- Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization.
- Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
- Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.
- Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.
- MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
Clinical Trials
Treatments
- Blood Cancers, Leukemia, Lymphoma And More
- Anemia
- Acute Myeloid Leukemia (aml)
- Leukemia
- Dermal Aesthetics
- Oral Surgery Procedures
- Extra Corporeal Shockwave Therapy
Professional Memberships
- Member American Society of Hematology
Dr. Michael J. Thirman M.D.'s Practice location
Dr. Michael J. Thirman M.D.'s reviews
Write ReviewPatient Experience with Dr. Thirman
Recommended Articles
- Is Lymphoma-related PTSD Possible?
PTSD is something that one may not think of right away when thinking of chronic or life-threatening illnesses, but it should not be overlooked. Post-traumatic stress disorder, or PTSD, can affect all aspects of a person’s life and requires treatment by a specialist.The Diagnostic and Statistical...
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- 7-year-old with Lymphoma Joins and Inspires Lacrosse Team
Sports have a way of bringing together families, strangers, and communities. All over the world people celebrate games and competitions and use them to lift people’s spirits and strengthen bonds. Sporting events are also frequently used to raise awareness about important causes, whether locally or...
- Overcoming Lymphoma: A South Philly Student's Story
In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...
- Treatments for Multiple Myeloma
The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
Nearby Providers
- Dr. Sowjanya Reganti M.D.,2160 S 1st Ave Maywood IL 60153
- Dr. Refat Baridi MD2320 High St Blue Island IL 60406
- Dr. Manjeet Chawla MD850 W Irving Park Rd Chicago IL 60613
- Dr. Nirmala Bhoopalam M.D.5TH AVENUE AND ROOSEVELT, HINES VA HOSPITAL HINES IL 60141
- Dr. Manuel Francisco Rosado M.D.5131 N Lincoln Ave Chicago IL 60625
- Dr. Aileen Go MD2160 S 1ST AVE MAYWOOD IL 60153